DEL Source was founded with the goal of providing rapid and cost-efficient small molecule DNA-Encoded Library (DEL) services with AIML capabilities to accelerate the drug discovery process through identifying novel chemical leads. We are a group of drug discovery experts with over 100+ years of collective experience in DEL platform capabilities, Medicinal Chemistry, and Discovery Biology. We offer comprehensive DEL chemical libraries and hit identification services enabled with AIML to accelerate your drug discovery programs.
Company Details
- Employees
- 5
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://del-source.com
Del Source Questions
Del Source's website is http://del-source.com
Del Source's LinkedIn profile is https://www.linkedin.com/company/del-source-inc
Del Source has
5 employees.
View email and phone details for 5
employees at Del Source.
Del Source's industry is
Biotechnology Research
Del Source's top competitors are
Sekkei Bio Private Limited,
Primas Bioscience Private Limited,
Glenmark Pharmaceuticals,
Ranbaxy,
Exo Therapeutics,
1859,
Aragen Life Sciences,
Vedtechbio,
Presude Lifesciences,
Bonito Biosciences.
Del Source's categories are Biotechnology Research
